autosomal recessive spinocerebellar ataxia 11

ORPHA: 2842712 Treatments Available

Contents

1. Overview
2. Available Treatments
3. Clinical Presentation
4. Classification & Codes

Overview

human disease

Available Treatments (2)

Drug	Form	Status	Countries	Lead Time
gabapentin	Oral capsule 100mg, 300mg, 400mg; Oral tablet 600mg, 800mg; Oral solution 250mg/5mL	FDA Approved, EMA Approved	11	3d
idebenone Orphan	oral tablet, 150 mg	EMA Approved	9	21d

Clinical Presentation

Signs and symptoms associated with autosomal recessive spinocerebellar ataxia 11, sourced from HPO and Orphanet clinical annotations.

Abnormality of ocular smooth pursuitIntellectual disabilityAtaxiaDysarthriaGlobal developmental delayCerebellar atrophyGait disturbanceLimb ataxiaTruncal ataxiaNystagmusDysphagiaUnsteady gaitGaze-evoked horizontal nystagmus

Classification & Codes

Orphanet Code

ORPHA:284271

autosomal recessive spinocerebellar ataxia 11

Orphanet	`ORPHA:284271`
Treatments	2 drug(s)
Symptoms on record	13 signs
Status	published

Treatment Summary

gabapentin idebenone· Orphan

Factual Authority

Last Updated3/20/2026

Clinical DataHPO · Orphanet

Drug DataFDA · EMA · CDSCO